UPDATE 4-Amneal cuts forecast as epinephrine shot supply issues linger, shares slump 36%
July 10, 2019 at 17:34 PM EDT
Shares of Amneal Pharmaceuticals Inc plunged 36% to an all-time low on Wednesday after the generic drugmaker cut its 2019 core earnings forecast due to supply uncertainties related to its epinephrine auto-injectors.
